Broadview Ventures
Overview
Broadview Ventures invests in businesses that focus on the development of technology solutions in cardiovascular and neurovascular diseases.
Investment Focus
- Innovative technologies in cardiovascular and neurovascular disease treatment
- Early-stage ventures with scalable solutions
- Companies with a clear path to commercialization and patient impact
Portfolio Companies
Reach Broadview Ventures directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Broadview Ventures
What sectors does Broadview Ventures invest in?
Broadview Ventures invests in Healthcare, Life Sciences, Pharmaceuticals, Medical Devices and Biotechnology, and is based in Toronto, Ontario, Canada. Broadview Ventures is listed as a vc in the ConnectSafely investor database.
What stage does Broadview Ventures invest at?
Broadview Ventures backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 500K - 50M.
Which regions does Broadview Ventures invest in?
Broadview Ventures invests across United States.
Who are the partners at Broadview Ventures?
Team members listed for Broadview Ventures include Tom Needham (Managing Director) and Christopher de Souza (Director).
What companies has Broadview Ventures invested in?
Broadview Ventures's portfolio includes XII Medical, AtaCor Medical, Alveron Pharmaceuticals, Cardiosense, Comanche Biopharma, CorFlow, IsomAb and Mosanna Therapeutics.
How do I contact Broadview Ventures?
Broadview Ventures's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
